Search - tctmd.com

Displaying 101 - 115 of 115

Sort: Relevancy | Date

News Daily News

基因检测不一定是 HCM 诊断的最后一根稻草

Yael L. Maxwell

August 23, 2016

News Daily News

Las Pruebas Genéticas No son Necesariamente la Prueba Concluyente en el Diagnóstico de la CMH

Yael L. Maxwell

August 23, 2016

News Daily News

Genetic Testing Not Necessarily the Nail in the Coffin for HCM Diagnosis

Yael L. Maxwell

August 23, 2016

News Daily News

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

Shelley Wood

June 14, 2016

News Daily News

Evidence Does Not Support Widespread Preparticipation ECG Screening in Young Athletes

Michael O'Riordan

April 22, 2016

News Conference News ACC 2016

Older Men With Existing Coronary Disease at Highest Risk of Dying During a Triathlon

Michael O'Riordan

April 06, 2016

News Industry News

MyoKardia Provides Update on Two Phase 1 Trials of MYK-461 for the Treatment of Hypertrophic Cardiomyopathy

October 07, 2015

News Featured Fellow

Jesse Naghi, MD

Yael L. Maxwell

June 11, 2015

News Industry News

Sanofi and MyoKardia Announce Groundbreaking Collaboration to Develop Targeted Therapies for Patients with Genetic Heart Disease

September 17, 2014

News Industry News

Boston Scientific Reports Key Data at the 35th Annual Scientific Sessions of the Heart Rhythm Society

May 05, 2014

News Daily News

Survival After Septal Ablation for HOCM Similar to General Population

L.A. McKeown

February 06, 2014

News Industry News

Heart Metabolics Receives Funding for U.S. Clinical Development of Heart Failure Drug

January 02, 2013

News Daily News

La Ablación Septal con Alcohol Rivaliza con la Miectomía en el Tratamiento de la Cardiomiopatía Hipertrófica Obstructiva

L.A. McKeown

October 23, 2012

News Daily News

Alcohol Septal Ablation Rivals Myectomy for Obstructive Hypertrophic Cardiomyopathy

L.A. McKeown

October 23, 2012

News Daily News

Percutaneous Septal Ablation for Hypertrophic Obstructive Cardiomyopathy Shows Low Mortality

L.A. McKeown

May 27, 2011

Advertisement

基因检测不一定是 HCM 诊断的最后一根稻草

Las Pruebas Genéticas No son Necesariamente la Prueba Concluyente en el Diagnóstico de la CMH

Genetic Testing Not Necessarily the Nail in the Coffin for HCM Diagnosis

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

Evidence Does Not Support Widespread Preparticipation ECG Screening in Young Athletes

Older Men With Existing Coronary Disease at Highest Risk of Dying During a Triathlon

MyoKardia Provides Update on Two Phase 1 Trials of MYK-461 for the Treatment of Hypertrophic Cardiomyopathy

Jesse Naghi, MD

Sanofi and MyoKardia Announce Groundbreaking Collaboration to Develop Targeted Therapies for Patients with Genetic Heart Disease

Boston Scientific Reports Key Data at the 35th Annual Scientific Sessions of the Heart Rhythm Society

Survival After Septal Ablation for HOCM Similar to General Population

Heart Metabolics Receives Funding for U.S. Clinical Development of Heart Failure Drug

La Ablación Septal con Alcohol Rivaliza con la Miectomía en el Tratamiento de la Cardiomiopatía Hipertrófica Obstructiva

Alcohol Septal Ablation Rivals Myectomy for Obstructive Hypertrophic Cardiomyopathy

Percutaneous Septal Ablation for Hypertrophic Obstructive Cardiomyopathy Shows Low Mortality

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content